| Lung Cancer Program Strategy |
Natalie Trebes |
The Advisory Board Company |
NLST |
Apr 28, 2015 |
NLST-137 |
| Standalone assessment of a CAD system for lung nodule detection |
Luca Bogoni |
Siemens Healthcare |
NLST |
Apr 27, 2015 |
NLST-136 |
| Image-guided Lung Intervention |
Jesse Mao |
Intuitive Surgical |
NLST |
Apr 17, 2015 |
NLST-134 |
| An analysis of the association between genetic variants and mitochondrial DNA copy number. |
Sonja Berndt |
NCI |
PLCO |
Apr 3, 2015 |
PLCO-140 |
| Lifestyle factors and health history among cancer survivors |
Mia Hashibe |
University of Utah |
PLCO |
Mar 23, 2015 |
PLCO-137 |
| Validation study of associations of medical conditions with subtypes of non-Hodgkin lymphoma |
Eric Engels |
NCI |
PLCO |
Mar 19, 2015 |
PLCO-138 |
| Autodetection of semantic features in pulmonary nodules |
Roger Chylla |
HealthMyne |
NLST |
Mar 18, 2015 |
NLST-129 |
| Longitudinal Prostate cancer prediction |
Jonathan Gelfond |
UT Health Science Center |
PLCO |
Mar 16, 2015 |
PLCO-135 |
| Designing and Implementing a Database Infrastructure for Large-Scale Biomedical Data |
Frank Meng |
UCLA |
NLST |
Mar 16, 2015 |
NLST-130 |
| Impact of Lung Cancer Screening on Lung Cancer mortality in COPD patients |
Juan Wisnivesky |
Icahn School of Medicine at Mount Sinai |
NLST |
Mar 13, 2015 |
NLST-128 |
| Survival and comorbidities among persons eligible for lung cancer screening |
David Howard |
Emory University |
NLST |
Mar 13, 2015 |
NLST-127 |
| Pre- and Post-diagnostic NSAID Use and Prostate Cancer Mortality among Prostate Cancer Cases |
Michael Cook |
HREB/DCEG/NCI |
PLCO |
Mar 13, 2015 |
PLCO-136 |
| Association between Genetic Variation and Gall Bladder Stones and Inflammation |
Jill Koshiol |
NCI |
PLCO |
Mar 11, 2015 |
PLCO-134 |
| Screening for COPD with Lung CT Densitometry |
Charles Hatt |
Imbio LLC |
NLST |
Mar 11, 2015 |
NLST-125 |
| Renal Cancer and Incidental Findings on Low-Dose CT |
Paul Pinsky |
NCI |
NLST |
Mar 11, 2015 |
NLST-126 |
| Epigenetic markers of multiple myeloma risk in peripheral blood DNA |
Kathryn Barry |
University of Maryland School of Medicine |
PLCO |
Mar 9, 2015 |
2015-0058 |
| Serum inflammation markers and esophageal adenocarcinoma risk |
Michael Cook |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0056 |
| Serum Levels of Autoantibodies and the Risk of Non-Hodgkin Lymphoma and Multiple Myeloma |
Jonathan Hofmann |
DCEG - Other |
PLCO |
Mar 9, 2015 |
2015-0051 |
| Pooled analysis of prospective cohort studies: the association between sex steroid hormones and esophageal/gastric cardia adenocarcinoma incidence |
Jessica Petrick |
NCI, DCEG, HREB |
PLCO |
Mar 9, 2015 |
2015-0040 |
| Development and validation of an oral cancer risk prediction model |
Anil Chaturvedi |
National Cancer institute |
PLCO |
Mar 9, 2015 |
PLCO-133 |
